Latest News

DiffBlue secures Goldman Sachs backing for AI suite of products

29th June 2017

All News | Financial News | Spinouts & Startups

The Oxford University AI company secures £17m as it unveils three AI-driven platforms.

Zegami to bring next-gen image and data search management tool to market

28th June 2017

All News | Spinouts & Startups

The Oxford University company secures £2.3m in Series A funding to translate image management platform for the consumer market.

Scenic Biotech’s ‘genetic off-switch’ for disease secures major investment to accelerate development

5th June 2017

All News | Financial News | Spinouts & Startups

Scenic Biotech, an international collaboration between Oxford University and Netherlands Cancer Institute, aims to unlock genetic potential in tackling cancer and other diseases with new funding.

Colwiz and Oxford Gene Technology complete successful exits in same week

2nd June 2017

All News | Financial News | Spinouts & Startups | Startup Incubator

Colwiz, a 2013 OUI Incubator company, and Oxford Gene Technology, a spinout 20 years in the making, both make successful trade sales.

Strokes targeted in new Brainomix collaboration

9th May 2017

All News | Spinouts & Startups

The Oxford spinout partners Boehringer on new initiative to combat one of Europe’s biggest killers.

Oxford University Innovation Quarterly Update: Q1 2017

26th April 2017

All News | Financial News | Spinouts & Startups

Roundup of news, deals, and data from OUI for Q1 2017.

Oxbotica’s autonomous vehicles gear up for London to Oxford trial

24th April 2017

All News | Spinouts & Startups

The Oxford University spinout leads newly formed DRIVEN consortium in most ambitious autonomous vehicle trials worldwide to date.

Oxford Cancer Biomarkers technologies licensed in China

19th April 2017

Spinouts & Startups

Spinout Oxford Cancer Biomarkers announces strategic collaboration with My-BioMed Biotechnology Co. Ltd, providing precision medicine to clinicians and patients in China

Oxford’s CN Bio targets Hepatitis in new deal

7th April 2017

All News | Spinouts & Startups

CN Bio Innovations secures licence from Bristol-Myers Squib to combine small molecule programme with liver-on-a-chip technologies to tackle Hepatitis.

Biochemical superglue bonds with SpyBiotech’s vision of next-generation vaccines

31st March 2017

All News | Spinouts & Startups

SpyBiotech, an Oxford University spinout developing a molecular superglue for rapid development of vaccines targeting a range of diseases, secures £4m seed funding at launch, led by Oxford Sciences Innovation with participation from GV.

News

Ready to get in touch?